EAGLE PHARMACEUTICALS INC. - COMMON STOCK

NetDania - New 12 months Low: EAGLE PHARMACEUTICALS INC. - COMMON STOCK

12 Dec 2023 08:47:38 By NetDania Notify

NetDania - New 12 months Low: EAGLE PHARMACEUTICALS INC. - COMMON STOCK

11 Dec 2023 09:37:01 By NetDania Notify

Eagle Pharmaceuticals to Present Abstract on Post-hoc Analysis of Amisulpride at the 77th PGA (PostGraduate Assembly in Anesthesiology) in New York City

06 Dec 2023 15:05:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: EAGLE PHARMACEUTICALS INC. - COMMON STOCK

29 Nov 2023 08:45:01 By NetDania Notify

Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

29 Nov 2023 06:35:00 By Nasdaq GlobeNewswire

Eagle Pharmaceuticals Announces Management Change

29 Nov 2023 06:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: EAGLE PHARMACEUTICALS INC. - COMMON STOCK

28 Nov 2023 08:48:28 By NetDania Notify

NetDania - New 12 months Low: EAGLE PHARMACEUTICALS INC. - COMMON STOCK

16 Nov 2023 10:02:22 By NetDania Notify

NetDania - New 12 months Low: EAGLE PHARMACEUTICALS INC. - COMMON STOCK

14 Nov 2023 10:34:59 By NetDania Notify

Eagle Delays Third Quarter 2023 Results and Conference Call

09 Nov 2023 06:30:00 By Nasdaq GlobeNewswire

Eagle Pharmaceuticals to Host Third Quarter 2023 Financial Results on November 9, 2023

08 Nov 2023 07:30:00 By Nasdaq GlobeNewswire

Eagle Pharmaceuticals Granted Patent for PEMFEXY®

24 Oct 2023 07:40:44 By Nasdaq GlobeNewswire

Eagle Pharmaceuticals Granted Unique J-Code and Pass-Through Status for BARHEMSYS® from CMS

23 Oct 2023 05:50:00 By Nasdaq GlobeNewswire

Eagle Pharmaceuticals Awarded First Prize for Poster to Be Presented at the International Society for Anaesthetic Pharmacology 32nd Annual Meeting

04 Oct 2023 05:50:00 By Nasdaq GlobeNewswire

Eagle Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023

19 Sep 2023 15:05:00 By Nasdaq GlobeNewswire

Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance

11 Sep 2023 05:50:00 By Nasdaq GlobeNewswire

Eagle Pharmaceuticals to Present BYFAVO® (remimazolam) for Injection Abstract at Prestigious Society for Neuroscience in Anesthesiology and Critical Care (SNACC) Conference

30 Aug 2023 05:50:00 By Nasdaq GlobeNewswire

Eagle Pharmaceuticals Announces Positive Type C Meeting with FDA for EA-114, an Estrogen Receptor Antagonist Used in the Treatment of Metastatic Breast Cancer in Post-Menopausal Women

29 Aug 2023 05:50:00 By Nasdaq GlobeNewswire

Eagle Pharmaceuticals to Present at Two Upcoming Healthcare Conferences

22 Aug 2023 15:05:00 By Nasdaq GlobeNewswire

Eagle Pharmaceuticals Reiterates 2023 Adjusted non-GAAP EBITDA and Adjusted non-GAAP E¹ Guidance

17 Aug 2023 05:50:00 By Nasdaq GlobeNewswire